Tenderwize
Retour à la recherche

Open House Originale Agreement for Tacrolimus (Retard Tablets)

Techniker Krankenkasse·Hamburg, Germany·Deadline May 30, 2027 · 277 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-15 - Tacrolimus (Retardtabletten)

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

The notice contains multiple end-date representations (structured data, XML notice, and timezone variants). This create...

Eligibility is restricted to pharmaceutical manufacturers with the required seat, authorisation, and reliability declar...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products, specifically Tacrolimus (retard tablets).
  • Open House original rebate agreements under Section 130c(1) SGB V.
Afficher le résumé complet

Open House supply arrangement for Tacrolimus (retard tablets) in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The notice states that any suitable pharmaceutical manufacturer may join during the contract period, but only if it meets the stated legal and reliability conditions and provides the required self-declarations. No contract value is stated. Electronic submission via the portal is not allowed; contracts must be submitted by email with qualified electronic signature or by post, and the procurement documents are available electronically but were not analyzed in extracted text beyond the notice XML.

Risques

The notice contains multiple end-date representations (structured data, XML notice, and timezone variants). This create...

Eligibility is restricted to pharmaceutical manufacturers with the required seat, authorisation, and reliability declar...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical manufacturer within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant product and/or otherwise be entitled to place it on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Agreement for Tacrolimus (Retard Tablets)

Supply arrangement for Tacrolimus (retard tablets) under an Open House procedure. Scope is nationwide in Germany. The lot information comes from structured data and XML notice. No lot value is stated. The contract can be joined at any time during the contract period, subject to eligibility and document requirements.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline May 30, 2027

Détails de la procédure

Date de publication
21 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
260054-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3